Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


19.02.2024

2 Am J Dermatopathol
3 J Am Acad Dermatol
3 Melanoma Res
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. CASILLAS AC, Muhlbauer A, Barragan VA, Jefferson I, et al
    A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations.
    Am J Dermatopathol. 2024;46:137-146.
    PubMed         Abstract available

  2. LOHMAN ME, Kim YH, Steen AJ, Demer AM, et al
    The Promise and Pitfalls of PRAME Immunohistochemistry During Mohs Surgery: Early Findings.
    Am J Dermatopathol. 2024;46:191-192.
    PubMed        


    J Am Acad Dermatol

  3. MORR C, Jade Prechtel T, Hardacker R, Bell M, et al
    Impact of skin cancer screening on melanoma thickness and stage.
    J Am Acad Dermatol. 2024 Feb 13:S0190-9622(24)00348.
    PubMed        

  4. NEALE H, Plumptre I, Belazarian L, Wiss K, et al
    Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi.
    J Am Acad Dermatol. 2024;90:e107-e108.
    PubMed        

  5. GRANT-KELS JM
    JAAD Game Changer: Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
    J Am Acad Dermatol. 2024;90:674.
    PubMed        


    Melanoma Res

  6. TEIXEIRA RJ, de Souza VG, Sorroche BP, Paes VG, et al
    Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy.
    Melanoma Res. 2024 Feb 16. doi: 10.1097/CMR.0000000000000958.
    PubMed         Abstract available

  7. ZHANG W, Wang S
    Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma.
    Melanoma Res. 2024 Feb 16. doi: 10.1097/CMR.0000000000000957.
    PubMed         Abstract available

  8. DE SMEDT J, Aura C, Van Kelst S, Janssen L, et al
    Clinical and genetic determinants of vitamin D receptor expression in cutaneous melanoma patients.
    Melanoma Res. 2024 Feb 13. doi: 10.1097/CMR.0000000000000929.
    PubMed         Abstract available


    PLoS One

  9. SHIRALKAR J, Anthony T, McCallum GA, Durand DM, et al
    Neural recordings can differentiate between spontaneously metastasizing melanomas and melanomas with low metastatic potential.
    PLoS One. 2024;19:e0297281.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.